What Happened to Maria Sharapova Doping Scandal?
Maria Sharapova, a five-time Grand Slam champion, tested positive for the banned substance meldonium at the 2016 Australian Open. She received an initial two-year ban, which was later reduced to 15 months upon appeal to the Court of Arbitration for Sport. Sharapova returned to tennis in 2017, retired in 2020, and has since focused on her business ventures and family life.
Quick Answer
Maria Sharapova tested positive for meldonium, a newly banned substance, at the 2016 Australian Open. She was initially banned for two years by the ITF, but this was reduced to 15 months by the Court of Arbitration for Sport, which found she bore 'less than significant fault'. Sharapova returned to professional tennis in April 2017, retired in February 2020, and is now a successful businesswoman, investor, and mother, having welcomed her son Theodore in 2022 and making public appearances as recently as February 2026.
📊Key Facts
📅Complete Timeline15 events
Meldonium Placed on WADA Monitoring List
The World Anti-Doping Agency (WADA) began monitoring meldonium due to evidence of its potential for abuse by athletes.
Meldonium Banned by WADA
Meldonium was officially added to WADA's list of prohibited substances, making its use illegal for athletes.
Positive Drug Test at Australian Open
Maria Sharapova provided a urine sample at the Australian Open that later tested positive for meldonium. This was the same day she lost to Serena Williams in the quarterfinals.
Informed of Failed Test
Sharapova was officially informed by the ITF that her sample from the Australian Open tested positive for meldonium.
Public Announcement of Failed Test
Maria Sharapova held a press conference in Los Angeles, publicly announcing her failed drug test and taking full responsibility.
Sponsors Suspend Deals
Major sponsors like Nike, Porsche, and Tag Heuer suspended their endorsement deals with Sharapova following her admission.
ITF Imposes Two-Year Ban
An independent tribunal appointed by the ITF suspended Maria Sharapova for two years, backdated to January 26, 2016, for violating anti-doping rules.
CAS Reduces Ban to 15 Months
The Court of Arbitration for Sport (CAS) reduced Sharapova's ban from two years to 15 months, stating she bore 'less than significant fault' and did not intend to cheat.
Return to Competitive Tennis
Maria Sharapova returned to the WTA Tour at the Porsche Grand Prix in Stuttgart, Germany, after her 15-month ban concluded.
Retirement from Professional Tennis
Sharapova announced her retirement from tennis at the age of 32 in an essay for Vogue and Vanity Fair, citing ongoing shoulder issues.
Engagement to Alexander Gilkes
Maria Sharapova announced her engagement to British businessman Alexander Gilkes.
Birth of Son Theodore
Sharapova and Alexander Gilkes welcomed their first child, a son named Theodore.
Joins Moncler Board of Directors
Sharapova joined the Board of Directors for the Italian luxury fashion brand Moncler, expanding her business portfolio.
International Tennis Hall of Fame Induction
Maria Sharapova was inducted into the International Tennis Hall of Fame.
Appearance at Winter Olympics
Maria Sharapova made a surprise appearance at the 2026 Winter Olympics, attending the women's figure skating event.
🔍Deep Dive Analysis
The 'Maria Sharapova doping' incident refers to the period surrounding her positive drug test for meldonium in January 2016. Sharapova, a prominent figure in women's tennis, announced on March 7, 2016, that she had failed a drug test at the Australian Open for meldonium, a substance she had been taking for health reasons for 10 years under the name Mildronate.
Meldonium, a Latvian-made drug primarily used for heart conditions, was added to the World Anti-Doping Agency (WADA) list of banned substances effective January 1, 2016, due to evidence of its use by athletes for performance enhancement. Sharapova stated she was unaware of the change, admitting she did not click a link in an email detailing the updated banned substances list. The International Tennis Federation (ITF) tribunal, however, found that she bore 'sole responsibility' and 'very significant fault' for the positive test, noting she had concealed her use of the drug from anti-doping authorities and her own team.
On June 8, 2016, the ITF imposed a two-year ban on Sharapova, backdated to January 26, 2016. This decision led to significant consequences, including the loss of ranking points and prize money from the Australian Open, and the suspension of lucrative sponsorship deals with major brands like Nike and Tag Heuer. Sharapova appealed the decision to the Court of Arbitration for Sport (CAS), arguing that she did not take the substance to enhance performance and that her period of ineligibility should be reduced.
In a key turning point, on October 4, 2016, the CAS reduced her ban from two years to 15 months, backdated to January 26, 2016. The CAS panel found that while she committed an anti-doping rule violation, her fault was 'not significant' and she could not be considered an 'intentional doper'. This allowed her to return to competitive tennis from April 26, 2017.
Sharapova officially retired from professional tennis on February 26, 2020, at the age of 32, citing ongoing shoulder injuries. Since her retirement, she has successfully transitioned into the business world. As of March 1, 2026, Sharapova is a prominent investor and entrepreneur. She continues to run her candy brand, Sugarpova, launched in 2012, and has invested in wellness brands like Therabody and skincare line Supergoop. In 2023, she joined the Board of Directors for the Italian fashion powerhouse Moncler. She is engaged to British businessman Alexander Gilkes, and they welcomed their son Theodore in July 2022. Sharapova was inducted into the International Tennis Hall of Fame in August 2025. She was also seen making a rare public appearance at the 2026 Winter Olympics in February 2026.